Because<unk>  lowers the release of immune system signalling molecules, patients may have a higher risk of getting infections from bacteria, viruses, and fungi. For this reason, people with psoriasis being considered for treatment with<unk>  must be screened for tuberculosis infection prior to treatment with<unk> . The most common side effects for<unk>  are upper respiratory tract infections, headache, injection site reactions, joint pain, diarrhea, gastroenteritis, fungal skin infections and herpes simplex infections. Because<unk>  is a new medicine, the long-term effects are not fully understood.
Guselkumab
Ustekinumab
Emapalumab
Olaratumab
Evolocumab
Dupilumab
Tralokinumab
Alirocumab